Validation of the Attention, Memory, and Frontal Abilities Screening Test (AMFAST)

Research output: Contribution to journalArticle

Abstract

The aim of this study is to validate the Attention, Memory, and Frontal Abilities Screening Test (AMFAST), a novel, 10-minute, paper-and-pencil measure developed to identify attention, processing speed, memory, and executive functioning deficits in children and adults with various conditions characterized by frontal-subcortical dysfunction. We administered the AMFAST to 186 English-speaking healthy control participants (aged 8-88 years) without reported cognitive impairment. The AMFAST was also administered to a mixed clinical sample that included 114 English-speaking individuals (aged 8-84 years) who also received comprehensive neuropsychological testing. Results indicated that total AMFAST scores in the healthy control sample were not significantly affected by education or gender. There was, however, a significant effect of age, as the 8- to 10-year-old group scored significantly lower than other age groups. Thus, only participants 11+ years were included in further analyses. The AMFAST demonstrated high test–retest and interrater reliabilities, good construct validity, and the identified optimal cutoff score of 70 had excellent sensitivity and specificity for differentiating between cognitively intact and cognitively impaired individuals. These findings demonstrate that the AMFAST is a highly effective screening test that can be used to identify attention, memory, processing speed, and executive functioning deficits in individuals from middle childhood through older adulthood.

Original languageEnglish (US)
JournalAssessment
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Aptitude
Healthy Volunteers
Age Groups
Education
Sensitivity and Specificity

Keywords

  • attention
  • cognitive assessment
  • cognitive screening
  • executive functioning
  • memory

ASJC Scopus subject areas

  • Clinical Psychology
  • Applied Psychology

Cite this

@article{085d7816fa5a4da0b3c282efe72285ab,
title = "Validation of the Attention, Memory, and Frontal Abilities Screening Test (AMFAST)",
abstract = "The aim of this study is to validate the Attention, Memory, and Frontal Abilities Screening Test (AMFAST), a novel, 10-minute, paper-and-pencil measure developed to identify attention, processing speed, memory, and executive functioning deficits in children and adults with various conditions characterized by frontal-subcortical dysfunction. We administered the AMFAST to 186 English-speaking healthy control participants (aged 8-88 years) without reported cognitive impairment. The AMFAST was also administered to a mixed clinical sample that included 114 English-speaking individuals (aged 8-84 years) who also received comprehensive neuropsychological testing. Results indicated that total AMFAST scores in the healthy control sample were not significantly affected by education or gender. There was, however, a significant effect of age, as the 8- to 10-year-old group scored significantly lower than other age groups. Thus, only participants 11+ years were included in further analyses. The AMFAST demonstrated high test–retest and interrater reliabilities, good construct validity, and the identified optimal cutoff score of 70 had excellent sensitivity and specificity for differentiating between cognitively intact and cognitively impaired individuals. These findings demonstrate that the AMFAST is a highly effective screening test that can be used to identify attention, memory, processing speed, and executive functioning deficits in individuals from middle childhood through older adulthood.",
keywords = "attention, cognitive assessment, cognitive screening, executive functioning, memory",
author = "Freilich, {Bryan M.} and Nicole Feirsen and Welton, {Elise I.} and Mowrey, {Wenzhu B.} and Rubinstein, {Tamar B.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/1073191118822734",
language = "English (US)",
journal = "Assessment",
issn = "1073-1911",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Validation of the Attention, Memory, and Frontal Abilities Screening Test (AMFAST)

AU - Freilich, Bryan M.

AU - Feirsen, Nicole

AU - Welton, Elise I.

AU - Mowrey, Wenzhu B.

AU - Rubinstein, Tamar B.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The aim of this study is to validate the Attention, Memory, and Frontal Abilities Screening Test (AMFAST), a novel, 10-minute, paper-and-pencil measure developed to identify attention, processing speed, memory, and executive functioning deficits in children and adults with various conditions characterized by frontal-subcortical dysfunction. We administered the AMFAST to 186 English-speaking healthy control participants (aged 8-88 years) without reported cognitive impairment. The AMFAST was also administered to a mixed clinical sample that included 114 English-speaking individuals (aged 8-84 years) who also received comprehensive neuropsychological testing. Results indicated that total AMFAST scores in the healthy control sample were not significantly affected by education or gender. There was, however, a significant effect of age, as the 8- to 10-year-old group scored significantly lower than other age groups. Thus, only participants 11+ years were included in further analyses. The AMFAST demonstrated high test–retest and interrater reliabilities, good construct validity, and the identified optimal cutoff score of 70 had excellent sensitivity and specificity for differentiating between cognitively intact and cognitively impaired individuals. These findings demonstrate that the AMFAST is a highly effective screening test that can be used to identify attention, memory, processing speed, and executive functioning deficits in individuals from middle childhood through older adulthood.

AB - The aim of this study is to validate the Attention, Memory, and Frontal Abilities Screening Test (AMFAST), a novel, 10-minute, paper-and-pencil measure developed to identify attention, processing speed, memory, and executive functioning deficits in children and adults with various conditions characterized by frontal-subcortical dysfunction. We administered the AMFAST to 186 English-speaking healthy control participants (aged 8-88 years) without reported cognitive impairment. The AMFAST was also administered to a mixed clinical sample that included 114 English-speaking individuals (aged 8-84 years) who also received comprehensive neuropsychological testing. Results indicated that total AMFAST scores in the healthy control sample were not significantly affected by education or gender. There was, however, a significant effect of age, as the 8- to 10-year-old group scored significantly lower than other age groups. Thus, only participants 11+ years were included in further analyses. The AMFAST demonstrated high test–retest and interrater reliabilities, good construct validity, and the identified optimal cutoff score of 70 had excellent sensitivity and specificity for differentiating between cognitively intact and cognitively impaired individuals. These findings demonstrate that the AMFAST is a highly effective screening test that can be used to identify attention, memory, processing speed, and executive functioning deficits in individuals from middle childhood through older adulthood.

KW - attention

KW - cognitive assessment

KW - cognitive screening

KW - executive functioning

KW - memory

UR - http://www.scopus.com/inward/record.url?scp=85059903346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059903346&partnerID=8YFLogxK

U2 - 10.1177/1073191118822734

DO - 10.1177/1073191118822734

M3 - Article

AN - SCOPUS:85059903346

JO - Assessment

JF - Assessment

SN - 1073-1911

ER -